← Back to Search

Walking for Exercise

N/A
Waitlist Available
Led By Paul L. Hebert, PhD BA
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have and be able to use a smart phone
Diagnosis of hypertension, depression or a BMI between 25-40
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline, week 12 and 24
Awards & highlights

Study Summary

This trial will test different incentive designs in a Veteran population to find an effective way to get Veterans to be more active.

Who is the study for?
This trial is for Veterans aged 50-69 who are physically inactive, have high blood pressure, depression or a BMI of 25-40. They must be able to use a smartphone and take 2,000-5,000 steps per day during the screening week. It's not for those with severe illnesses like metastatic cancer or heart failure, pregnant women, or those in assisted living.Check my eligibility
What is being tested?
The study tests if incentives can encourage Veterans to walk more regularly as part of their routine. Different types of rewards will be used to see which works best at motivating participants to exercise and whether this behavior continues after the incentives end.See study design
What are the potential side effects?
Since the intervention involves walking as physical activity, potential side effects may include muscle soreness or strain from increased activity levels. However, these are generally mild and improve with regular exercise.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I own and can use a smartphone.
Select...
I have high blood pressure, depression, or my BMI is between 25-40.
Select...
I walk between 2,000 and 5,000 steps daily.
Select...
I am between 50 and 69 years old.
Select...
I walk between 2,000 and 5,000 steps daily.
Select...
I am between 50 and 69 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline, week 12 and 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline, week 12 and 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in average steps per day from baseline week to week 12
Secondary outcome measures
Intrinsic/extrinsic motivation
Mental health
Self-efficacy

Trial Design

16Treatment groups
Experimental Treatment
Group I: N1M1P1R1Experimental Treatment1 Intervention
Non-financial reward, mixed lottery, pre-commitment postcard reminders, request physical activity advice
Group II: N1M1P1R0Experimental Treatment1 Intervention
Non-financial reward, mixed lottery, pre-commitment postcard reminders, no request physical activity advice
Group III: N1M1P0R1Experimental Treatment1 Intervention
Non-financial reward, mixed lottery, no pre-commitment postcard reminders, request physical activity advice
Group IV: N1M1P0R0Experimental Treatment1 Intervention
Non-financial reward, mixed lottery, no pre-commitment postcard reminders, no request physical activity advice
Group V: N1L1P1R1Experimental Treatment1 Intervention
Non-financial reward, loss incentive, pre-commitment postcard reminders, request physical activity advice
Group VI: N1L1P1R0Experimental Treatment1 Intervention
Non-financial reward, loss incentive, pre-commitment postcard reminders, no request physical activity advice
Group VII: N1L1P0R1Experimental Treatment1 Intervention
Non-financial reward, loss incentive, no pre-commitment postcard reminders, request physical activity advice
Group VIII: N1L1P0R0Experimental Treatment1 Intervention
Non-financial reward, loss incentive, no pre-commitment postcard reminders, no request physical activity advice
Group IX: F1M1P1R1Experimental Treatment1 Intervention
Financial Reward, mixed lottery, pre-commitment postcard reminders, request physical activity advice
Group X: F1M1P1R0Experimental Treatment1 Intervention
Financial Reward, mixed lottery, pre-commitment postcard reminders, no request physical activity advice
Group XI: F1M1P0R1Experimental Treatment1 Intervention
Financial Reward, mixed lottery, no pre-commitment postcard reminders, request physical activity advice
Group XII: F1M1P0R0Experimental Treatment1 Intervention
Financial Reward, mixed lottery, no pre-commitment postcard reminders, no request physical activity advice
Group XIII: F1L1P1R1Experimental Treatment1 Intervention
Financial Reward, loss incentive, pre-commitment postcard reminders, request physical activity advice
Group XIV: F1L1P1R0Experimental Treatment1 Intervention
Financial Reward, loss incentive, pre-commitment postcard reminders, no request physical activity advice
Group XV: F1L1P0R1Experimental Treatment1 Intervention
Financial Reward, loss incentive, no pre-commitment postcard reminders, request physical activity advice
Group XVI: F1L1P0R0Experimental Treatment1 Intervention
Financial Reward, loss incentive, no pre-commitment postcard reminders, no request physical activity advice
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Walking
2020
Completed Phase 2
~1570

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,605 Previous Clinical Trials
3,305,496 Total Patients Enrolled
3 Trials studying Exercise
528 Patients Enrolled for Exercise
Paul L. Hebert, PhD BAPrincipal InvestigatorVA Puget Sound Health Care System Seattle Division, Seattle, WA
1 Previous Clinical Trials
274 Total Patients Enrolled

Media Library

Walking Clinical Trial Eligibility Overview. Trial Name: NCT04518943 — N/A
Exercise Research Study Groups: F1L1P1R1, N1L1P1R1, N1L1P0R0, N1L1P0R1, F1L1P1R0, F1L1P0R0, F1M1P1R0, N1M1P0R0, N1M1P1R1, N1L1P1R0, F1M1P0R0, F1M1P0R1, N1M1P1R0, F1L1P0R1, F1M1P1R1, N1M1P0R1
Exercise Clinical Trial 2023: Walking Highlights & Side Effects. Trial Name: NCT04518943 — N/A
Walking 2023 Treatment Timeline for Medical Study. Trial Name: NCT04518943 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still slots available to join this research initiative?

"Affirmative. According to clinicaltrials.gov's records, this medical trial is actively enlisting participants as of now. It was initially uploaded on March 17th 2022 and most recently modified on July 14th 2022; 200 patients are being recruited from a single site."

Answered by AI

How many individuals are involved in the clinical trial?

"Affirmative. Clinicaltrials.gov indicates that the study was initiated on March 17th, 2022 and modified most recently on July 14th, 2022. At this time 200 participants are being recruited at one research centre."

Answered by AI

Are geriatric individuals excluded from this medical trial?

"This medical experiment is offering its services to people aged between 50 and 69."

Answered by AI

What is the eligibility criteria for enrolment in this experiment?

"This clinical research is enrolling two-hundred participants aged fifty to sixty-nine. Amongst the criteria they must meet are physical inactivity as self reported, a step count of between 2000 and 5000 during screening week, possession of a smart phone, and falling within the specified age range."

Answered by AI

Who else is applying?

What state do they live in?
Washington
How old are they?
18 - 65
What site did they apply to?
VA Puget Sound Health Care System Seattle Division, Seattle, WA
What portion of applicants met pre-screening criteria?
Met criteria
~33 spots leftby Mar 2025